Cutaneous manifestations of DOCK8 deficiency syndrome - Wikidata - wikimedia - TriplyDB

Cutaneous manifestations of DOCK8 deficiency syndrome

Cutaneous manifestations of DOCK8 deficiency syndrome

http://www.wikidata.org/entity/Q33921708

about

Primary immunodeficiencies associated with eosinophilia Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation Actin cytoskeletal defects in immunodeficiency Mendelian genetics of human susceptibility to fungal infection Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity Cellular and Molecular Defects Underlying Invasive Fungal Infections-Revelations from Endemic Mycoses.Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency.Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype.A 17-year old patient with DOCK8 deficiency, severe oral HSV-1 and aggressive periodontitis - a case of virally induced periodontitis?Delayed control of herpes simplex virus infection and impaired CD4(+) T-cell migration to the skin in mouse models of DOCK8 deficiency Staphylococcus aureus: an introduction The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.Warts and all: human papillomavirus in primary immunodeficiencies.Partial defects of T-cell development associated with poor T-cell function.Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency.Recent Advances in DOCK8 Immunodeficiency Syndrome.Additional diverse findings expand the clinical presentation of DOCK8 deficiency.DOCK8 is critical for the survival and function of NKT cells TH17 deficiency in human disease.Skin manifestations of primary immune deficiency.Common dermatologic manifestations of primary immune deficiencies.Important differences in the diagnostic spectrum of primary immunodeficiency in adults versus children.DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.Hyper-IgE Syndromes and the Lung.Current Status of Dedicator of Cytokinesis-Associated Immunodeficiency: DOCK8 and DOCK2.DOCK8 deficiency: Insights into pathophysiology, clinical features and management.Genetic Predictors of Susceptibility to Dermatophytoses.Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide.Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.Novel dedicator of cytokinesis 8 mutations identified by multiplex ligation-dependent probe amplification.A novel large deletion of the DOCK8 gene in a Chinese family with autosomal-recessive hyper-IgE syndrome.Approach to a Child with Primary Immunodeficiency Made Simple.Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen.The human skin microbiome.Autosomal-Recessive Hyper-IgE Syndrome.Primary immunodeficiency diseases in lung disease: warning signs, diagnosis and management

P2860

Q26746046-E200A564-6F51-45E6-A9A5-AE0669A83A85 Q26799603-E3A55B36-823B-4CA0-A470-2B3A963D1D7E Q27021852-ECE5FB64-0F1A-47E0-97AE-8181F1E50EA6 Q27022250-78A4CAD8-88D2-4DC1-9CDE-2DDF02C070BF Q27693832-AB609E5A-F943-4B3E-901D-3AAC17099C09 Q28086897-12C70151-B048-4B67-B596-8ED1C92365C7 Q30608340-7085AD05-3739-4A7C-9D07-08CD3622AD0D Q33843057-2B59477E-F897-455F-BE05-D916E28945AE Q33956861-3196B0C5-353E-48FE-882E-F8632DF73AFF Q34042360-E43765DA-3310-44B3-A5A5-7B9BCE845E3F Q35082392-003CC8FB-AE70-4815-BA76-6A885B4A836A Q35832670-95A48F03-CE5C-4FFA-B226-7133307FD51A Q35884684-2FB126B3-0F30-4636-9747-9E1236E2272E Q35931565-B9A82785-1E8C-4CA5-9494-851F4E2B9A24 Q36455030-A6BE8632-722F-4118-B780-5ACDAABCF572 Q36808097-30CBD488-34DF-4D9A-A7A9-D8EDDE4D3225 Q36822977-887090C5-4678-45DB-B32E-A1580291E4B2 Q37022547-CD2C0349-176E-47B5-96DB-A6A454099C6A Q37068033-04FA531D-E6B1-479C-89E1-963EE60E8821 Q37186461-0918616F-60A0-48BA-9E3C-EC2679DA424F Q38007258-502A1705-F4F3-4988-8102-7CFF2AC14245 Q38113986-F1DB3D53-49B8-4B13-A6A8-5B81ECF1308B Q38255586-64999B5F-1FE8-4074-9E25-52E5E29FB4C9 Q38306637-535AD98C-CE7C-4D6A-84C6-3A3C0173C64D Q38334918-BB304B1F-ED4F-48AB-AEB3-CA5471BFEEC5 Q38925032-EE42ED4A-464B-40E6-93EA-5F49E7D93802 Q39021324-F406A983-D11E-42F0-81E5-84B50D93871F Q39381359-64B004CE-1529-4CB0-902E-3E132441119E Q39511094-7E33D9DE-DAB9-49D1-B35E-34C9CC3CDDBA Q40296052-547B1BB4-E633-4810-9243-15E5E146BEA5 Q40900667-9DB5E6BA-4332-4FAE-95BD-F1A04A7B43AA Q42254894-38A89A25-4718-4297-91E5-7E7347C631BE Q45114560-24AE33FE-5B9C-4C05-92FA-889AE83554C2 Q47095589-66BBB5AD-A508-41A7-BBCC-91DBE3C8AF32 Q49098748-DC0D5452-519B-4549-AACA-80E3089D065E Q50051002-DF1302EE-FCA8-4B45-A39B-C308DD8EF112 Q52661802-532FBE35-C3E6-44D0-8548-0DAC79045C8D Q59127411-97A84E05-ED74-4E50-BC7D-8CA6A2957B4B

P2860

Cutaneous manifestations of DOCK8 deficiency syndrome

http://www.wikidata.org/entity/Q33921708

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cutaneous manifestations of DOCK8 deficiency syndrome

@ast

Cutaneous manifestations of DOCK8 deficiency syndrome

@en

type

label

Cutaneous manifestations of DOCK8 deficiency syndrome

@ast

Cutaneous manifestations of DOCK8 deficiency syndrome

@en

prefLabel

Cutaneous manifestations of DOCK8 deficiency syndrome

@ast

Cutaneous manifestations of DOCK8 deficiency syndrome

@en

P1433

Q33921708-77433804-6047-46C9-B160-F3B85AB21CB6

P1476

Q33921708-BD855D80-7C62-49A2-B2D2-1F708E2CFE9E

P2093

Q33921708-04AD4FD4-B953-48C4-9246-2F75CA1EEC2C

Q33921708-21993FFD-C777-4701-9040-168330B1BA9D

Q33921708-963BFEB8-4779-4793-BB80-A668A3CAB548

Q33921708-9A924EAE-BEC9-47F1-8CED-ACD37797D0C3

Q33921708-ACD77565-B726-4599-BDA6-DB115C8B0478

Q33921708-C2F07425-F259-41C7-A70F-E5CB4683B8AB

Q33921708-E00C103C-6B9D-4F4B-BE4B-1879ADF0CCD2

Q33921708-FD08457A-2B3C-4AA3-A8E0-8B24A361320C

P2860

Q33921708-1596AC56-B2E9-412E-803B-2AED59381B30

Q33921708-19C34079-4462-4AB7-A871-99CEC8B26256

Q33921708-1A763313-6D09-4942-A260-5F4B2622ED34

Q33921708-202BC20D-58BD-4989-8CC1-D439FE7B1654

Q33921708-26A1EA6F-D9B9-4461-BEC4-E79679FFB5F6

Q33921708-2C353373-7FF2-43F0-9F89-7CDF2C4C538E

Q33921708-46914D86-7473-4FC7-9456-79CFCBCBB1F7

Q33921708-5057688C-986F-49C1-A402-E305CC5AE38C

Q33921708-596B65AE-973A-4C70-8608-13373A10254D

Q33921708-6EDC67A9-A6AF-4E6E-B61F-348DE2614E12

P304

Q33921708-0D7CA26B-41D6-4F3D-BB00-0E1A0BC16E29

P31

Q33921708-85BC1A52-DCBD-4160-9F87-075F3B4DD56D

P356

Q33921708-370B0C3B-C5FC-4D76-A0D3-C8CA7B4E3D3F

P433

Q33921708-0FBB0054-ED44-429A-BEDE-E53D28910AD2

P478

Q33921708-DFF37D6E-826B-4DE6-AC24-D4111643D68C

P577

Q33921708-01F7D2AE-11F8-47FE-A839-C1159D844955

P5875

Q33921708-413756C5-CEB9-421A-84FC-C134921F1CC5

P698

Q33921708-6B4C3392-00BE-47A2-A424-A6D5CD451BF1

P932

Q33921708-3F85E441-F02D-4960-80AC-464F5047FD66

P356

ARCHDERMATOL.2011.262

P1433

JAMA Dermatology

P1476

Cutaneous manifestations of DOCK8 deficiency syndrome

@en

P2093

Alexandra F Freeman

http://www.w3.org/2001/XMLSchema#string

Edward W Cowen

http://www.w3.org/2001/XMLSchema#string

Emily Y Chu

http://www.w3.org/2001/XMLSchema#string

Helen C Su

http://www.w3.org/2001/XMLSchema#string

Huie Jing

http://www.w3.org/2001/XMLSchema#string

Joie Davis

http://www.w3.org/2001/XMLSchema#string

Maria L Chanco Turner

http://www.w3.org/2001/XMLSchema#string

Steven M Holland

http://www.w3.org/2001/XMLSchema#string

P2860

Combined immunodeficiency associated with DOCK8 mutations

STAT3 mutations in the hyper-IgE syndrome

Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity

Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

Stem-cell gene therapy for the Wiskott-Aldrich syndrome.

Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.

Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.

Dedicator of cytokinesis 8 (DOCK8) deficiency

Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome.

P304

79-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHDERMATOL.2011.262

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51655245

http://www.w3.org/2001/XMLSchema#string

P698

21931011

http://www.w3.org/2001/XMLSchema#string

P932

4103903

http://www.w3.org/2001/XMLSchema#string